Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
Clinical trial NCT04010071 · UNKNOWN
Trial details
- NCT number
- NCT04010071
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2024-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.